Vaishali Pharma - Quaterly Results

07 Aug 2023 Evaluate
The Sales for the quarter ended June 2023 of Rs. 134.23 millions rose by 31.86% from Rs. 101.80 millions.A meek growth of 4.89% was reported for the quarter ended June 2023 to Rs. 15.86  millions from Rs. 15.12 millions.Operating profit for the quarter ended June 2023 rose to 26.69 millions as compared to 26.33 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 134.23 101.80 31.86 134.23 101.80 31.86 696.63 758.21 -8.12
Other Income 3.61 4.34 -16.82 3.61 4.34 -16.82 22.29 17.88 24.66
PBIDT 26.69 26.33 1.37 26.69 26.33 1.37 113.58 86.43 31.41
Interest 4.30 5.29 -18.71 4.30 5.29 -18.71 20.09 24.59 -18.30
PBDT 22.39 21.04 6.42 22.39 21.04 6.42 93.49 61.84 51.18
Depreciation 1.20 0.88 36.36 1.20 0.88 36.36 5.04 4.56 10.53
PBT 21.19 20.16 5.11 21.19 20.16 5.11 88.45 57.28 54.42
TAX 5.33 5.04 5.75 5.33 5.04 5.75 22.42 17.05 31.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.04 -0.18 -122.22
PAT 15.86 15.12 4.89 15.86 15.12 4.89 66.03 40.23 64.13
Equity 105.96 105.46 0.47 105.96 105.46 0.47 105.46 105.46 0.00
PBIDTM(%) 19.88 25.86 -23.12 19.88 25.86 -23.12 16.30 11.40 43.03
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.